Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cardiovascular Diseases × Pyruvic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Metabolic Syndrome 1 Heart Failure 1 Cardiovascular Diseases 1

Interventions

xinmailong 1 pembrolizumab 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Sugars 1 Pyruvic Acid 1 Linseed Oil 1 Gonadotropin-Releasing Hormone 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06645691 2024-12-06

POLARIC-13

National Heart Centre Singapore

Phase 2 Recruiting

Cardiovascular Diseases, Heart Failure, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡